Biocodex
North America, California, United States, San Bruno
Description
An International Pharmaceutical Company.
Investor Profile
Biocodex has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series A, Series B rounds (top funding stages).
- Majority of deals are located in France.
- Strong thematic focus on Biotechnology, Health Care, Biopharma.
- Led 1 rounds in the past year.
Stage Focus
- Post Ipo Equity (40%)
- Series A (40%)
- Series B (20%)
Country Focus
- France (100%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
